DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ:ABMD) announces the appointment of Paula A. Johnson, MD, MPH, to the Abiomed Board of Directors, effective immediately. Dr. Johnson will serve as a member of the Governance and Nominating Committee of the board. Following the appointment of Dr. Johnson, the board now comprises nine active directors. “Dr. […]
Other News
BRUKINSA® (Zanubrutinib) Demonstrates Superior Objective Response Rate by Investigator Assessment and Reduced Rates of Atrial Fibrillation or Flutter at Interim Analysis in Head-to-Head Trial Against Ibrutinib in Chronic Lymphocytic Leukemia
CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–BeiGene (NASDAQ: BGNE; HKEX: 06160) announced positive results from a planned interim analysis of the Phase 3 ALPINE trial comparing BRUKINSA® (zanubrutinib) against ibrutinib in adults with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). BRUKINSA met the primary endpoint of the […]
Connect For Education and Starting Hearts Announce the Launch of their Powerful Online Education Program and Training Platform
Online Training Course Aims to Improve Outcomes for Sudden Cardiac Arrest Victims HERNON, Va., April 27, 2021 /PRNewswire/ — Connect For Education Inc. (C4E), a leading provider of online education technologies, is proud to announce a successful launch of Call.Push.Shock, a highly-interactive online training and education curriculum that provides users of all ages […]
Esperion Announces Publication of Rationale and Design of Landmark CLEAR Cardiovascular Outcomes Trial Evaluating NEXLETOL® (bempedoic acid) Tablet in American Heart Journal
– First-of-its-kind outcomes trial designed to assess cardiovascular risk reduction in patients with documented intolerance to statin therapy – – Nearly half of trial participants are women, a significantly higher proportion than have been included in any other previous cardiovascular outcomes study in history – – Event driven MACE (major […]
CHF Solutions Expands Commercial Focus, Changes Name to Nuwellis
The new name reflects the company’s commitment to pediatric, critical care, and chronic heart failure patients EDEN PRAIRIE, Minn., April 27, 2021 (GLOBE NEWSWIRE) — Company names are reflective of the services provided to its customers, and CHF Solutions – a leader and pioneer in the heart failure space – […]
BioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona
Westport, CT, April 27, 2021 (GLOBE NEWSWIRE) — The clinic is conducting an evaluation of the PURE EP(tm) System, a signal processing technology for cardiac arrhythmia treatments New installation follows Mayo Clinic in Florida that has been conducting patient cases with the technology since January 2020 BioSig Technologies, Inc. (NASDAQ: […]
James R. Tobin, Former CEO of Boston Scientific, Joins Xenter, Inc. Board of Directors to Assist in Advance of Device/Data/Drug Technologies
-Xenter’s next-generation technology advances interventional medicine by integrating functions that formerly required multiple devices- SALT LAKE CITY–(BUSINESS WIRE)–On the heels of its April 7 launch announcement, Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced that James R. Tobin has been appointed to the company’s Board of Directors. Founded […]
Peijia Medical’s TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercialization
SUZHOU, China, April 24, 2021 /PRNewswire/ — A new interventional solution from China for structural heart disease is about to be launched onto the market. Recently, TaurusOne® Transcatheter Aortic Valve Replacement System (hereinafter referred to as “TaurusOne®“) developed by Peijia Medical (Suzhou) Co., Ltd., located in Suzhou Industrial Park, Jiangsu Province, was officially approved for commercialization […]
Phoenix Cardiac Receives CE Mark for its Innovative BACE Device to Treat Functional Mitral Regurgitation
Novel device designed to address the root cause of mitral regurgitation, avoiding the need for open-heart surgery Company seeks partner to conduct a pivotal study in pursuit of a heart failure indication Clinical data supporting CE Mark to be presented as a late-breaking oral presentation at the virtual AATS 101st […]
Medtronic Partners with Surgical Theater to Provide First Augmented Reality Platform for Use in Real-Time During Complex Cranial Procedures
SyncAR™ Technology Uniquely Integrates with StealthStation™ S8 Surgical Navigation System and Expands the Use of Augmented Reality Into Operating Rooms to Enhance Precision and Efficiency DUBLIN and LOS ANGELES, April 26, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, and Surgical Theater today announced a partnership to interface Surgical Theater’s SyncAR™ augmented reality (AR) […]



